Bharat Immunologicals and Biologicals Corporation Limited

Bharat Immunologicals and Biologicals Corporation Limited
Name	Bharat Immunologicals and Biologicals Corporation Limited
Type	Public Sector Undertaking
Founded	1976
Headquarters	Bulandshahr, Uttar Pradesh, India
Products	Vaccines, antisera, biologics
Owner	Government of India

Bharat Immunologicals and Biologicals Corporation Limited is an Indian public sector enterprise focused on production of vaccines, antisera and other biologics. It operates a manufacturing complex in Bulandshahr, Uttar Pradesh, and collaborates with national and international agencies for immunization programs, emergency response, and technology transfer. The corporation supplies products to national immunization initiatives and has engaged with research institutes and regulatory bodies for quality assurance and product development.

History

The corporation was established in 1976 during a period of public health expansion in India linked to policies by the Ministry of Health and Family Welfare and the Government of India. Its origins intersect with initiatives by the World Health Organization, the United Nations Children's Fund, and national schemes such as the Expanded Programme on Immunization which followed global efforts exemplified by the Smallpox Eradication Programme. Early partnerships included technical assistance from agencies like the Indian Council of Medical Research and the Central Drugs Standard Control Organization, and it operated within the broader context of industrial policy debates involving the Planning Commission of India and state-level administrations in Uttar Pradesh. Over subsequent decades, the corporation adapted to regulatory reforms influenced by the Drugs and Cosmetics Act and international standards articulated by entities such as the World Health Assembly and the Food and Agriculture Organization. Its trajectory reflects interactions with public health events including outbreaks addressed by the National Institute of Virology, and policy shifts tied to programmes like the National Rural Health Mission and Pulse Polio Programme.

Products and Vaccines

The product portfolio encompasses inactivated and live-attenuated vaccines, antisera, and bulk biologics used in immunization campaigns overseen by the Ministry of Health and Family Welfare and distributed via mechanisms similar to those used by National Polio Surveillance Project and state health departments like the Directorate of Health Services, Uttar Pradesh. Vaccines produced have included formulations relevant to the Polio Eradication Initiative, agents used historically in combatting diseases comparable to those targeted under the Smallpox Eradication Programme and the Expanded Programme on Immunization. The company’s outputs have been evaluated against standards set by the Central Drugs Standard Control Organization and international guidelines from the World Health Organization and the Global Alliance for Vaccines and Immunization. Product distribution networks intersect with procurement mechanisms such as those used by the National Cold Chain Vaccine Management, state procurement cells in Madhya Pradesh, Bihar, and collaborations with agencies like United Nations Development Programme and Gavi, the Vaccine Alliance.

Manufacturing Facilities and Technology

The primary manufacturing complex is located near Bulandshahr in Uttar Pradesh and includes production lines for vaccine formulation, aseptic filling, and cold storage compatible with cold chain logistics similar to systems used at the National Cold-chain Project. Facilities adhere to norms influenced by the Central Drugs Standard Control Organization and quality frameworks developed by the World Health Organization. Technology platforms have been updated via collaborations with institutions like the Indian Institute of Technology Delhi, National Institute of Immunology, All India Institute of Medical Sciences and technology providers connected to industrial clusters supported by the Department of Biotechnology and Small Industries Development Bank of India. The site’s biosafety and containment practices align with guidelines from the Indian Council of Medical Research and training programmes supported by the National Institute of Virology.

Research and Development

R&D activities have been performed in collaboration with national research bodies including the Indian Council of Medical Research, the Department of Biotechnology, and university partners such as Banaras Hindu University and Aligarh Muslim University. Projects have involved assay development, antigen purification, and process optimization drawing on expertise from the National Institute of Immunology, the Central Drugs Laboratory, and research consortia modeled on partnerships seen with institutions like the Council of Scientific and Industrial Research. The entity has sought technology transfer and capacity building through ties with international organizations such as the World Health Organization, United Nations Children's Fund, and networks connected with Gavi, the Vaccine Alliance for programmatic research addressing vaccine accessibility and cold chain resilience.

Governance and Ownership

Ownership is vested in the Government of India with administrative oversight involving the Ministry of Health and Family Welfare and interfaces with regulatory bodies such as the Central Public Sector Enterprises framework and the Department of Public Enterprises. Governance structures reflect accountability mechanisms similar to those applied across public sector undertakings interacting with the Comptroller and Auditor General of India and follow compliance expectations articulated by the Central Vigilance Commission and procurement norms observed by state procurement agencies in Uttar Pradesh.

Market Presence and Partnerships

Market engagement includes supply contracts with national immunization programmes, state health departments across India including Uttar Pradesh, Maharashtra, Tamil Nadu, and participation in emergency responses coordinated with the National Centre for Disease Control and the Ministry of Home Affairs during public health emergencies. Partnerships have been formed with international agencies like the World Health Organization, United Nations Children's Fund, Gavi, the Vaccine Alliance, and bilateral cooperation channels modeled on arrangements seen with the United Kingdom Department for International Development and the United States Agency for International Development. Commercial and institutional linkages extend to academic collaborators such as the All India Institute of Medical Sciences and technology partners engaged via the Department of Biotechnology and public procurement frameworks operating under the Central Public Procurement Portal.

Category:Biopharmaceutical companies of India Category:Government-owned companies of India Category:Organizations based in Uttar Pradesh